Results 271 to 280 of about 6,974,500 (303)

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease   +20 more
wiley   +1 more source

Updated COVID‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions

open access: yesArthritis &Rheumatology, EarlyView.
Objective We aimed to assess the association between COVID‐19 vaccination status and COVID‐19‐related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECMO), and death in people with autoimmune rheumatic conditions. Methods We conducted a retrospective cohort study using National Clinical Cohort Collaborative
Lesley E. Jackson   +127 more
wiley   +1 more source

Plasma proteome reflects tissue damage and clinical manifestations in patients with inflammatory myopathies

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Tissue‐specific biomarkers that are reliable and associated with clinical manifestations of idiopathic inflammatory myopathy (IIM) are lacking. The blood circulation in individuals serves as a central conduit, allowing communication between tissues and facilitating clearance and recycling of tissue‐derived proteins.
Yue‐Bei Luo   +23 more
wiley   +1 more source

Single-Cell and Bulk Transcriptomics Reveal an Epithelial <i>LTF</i>-<i>LRP11</i> Signaling Axis Associated with Severe COVID-19 Susceptibility. [PDF]

open access: yesGenes (Basel)
Labbate Bonaldo AL   +9 more
europepmc   +1 more source

Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury Pattern. [PDF]

open access: yesEur J Immunol
Ruhl L   +13 more
europepmc   +1 more source

Exercise-Based Rehabilitation in Severe COVID-19 Survivors with Long COVID: A Randomized Controlled Pilot Study. [PDF]

open access: yesMed Sci (Basel)
Pinto EF   +7 more
europepmc   +1 more source

The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19. [PDF]

open access: yesPLoS One
Bayaraa O   +5 more
europepmc   +1 more source

Analysis of Bacterial Coinfections in Patients with Mild, Moderate, and Severe COVID-19. [PDF]

open access: yesPol J Microbiol
Liu Q   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy